A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab pre-treated patients with Her2-positive metastatic breast cancer - E-Vita - - Bischoff, Joachim; Marmé, Frederik (Annals of oncology, 2016)
Gesehen am 09.11.2017